Continuous subcutaneous insulin infusion (CSII) has become an indispensable modality in the management of type 1 diabetes. This therapy employs an insulin pump to deliver both basal and bolus doses, ...

The development of an insulin infusion protocol was initiated by key contributors from a team of nurses, dietitians, pharmacists, and physicians. The physician members were from various specialties, ...

There may be another leap toward an artificial pancreas thanks to new research released by Animas Corp. At the Advanced Technologies & Treatments for Diabetes Conference in February, the company, part ...

Please provide your email address to receive an email when new articles are posted on . Of 20 hospitals providing insulin algorithms, 60% stated which patients should initiate basal or nutritional ...

The Food and Drug Administration has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with Type 1 diabetes. These two devices, along ...

Hospitalized patients with complex dietary restrictions often develop hyperglycemia, or high blood sugar. This occurs in roughly one-quarter to one-half of these patients and can lead to serious ...

Significant advancements in diabetes management have marked the evolution of insulin delivery methods. Insulin was initially administered through injections, often leading to inconsistent blood ...